Telescope Innovations Corp. (CSE:TELI)
Canada · Delayed Price · Currency is CAD 0.4500
0.00 (0.00%)
Jan 13, 2026, 3:59 PM EST
Telescope Innovations Company Description
Telescope Innovations Corp., a chemical technology company, develops manufacturing processes and tools for the pharmaceutical and chemical industry in the United States and Canada.
It offers DIRECTINJECT-LCTM, a hardware and software ecosystem that enables direct sampling and analysis of chemical reactions.
It also provides intellectual property and contract research services. It serves pharmaceutical, critical minerals, and chemical industries.
Telescope Innovations Corp. has a research collaboration with Pfizer Inc; and Standard Lithium Ltd. to develop a method for producing high-purity lithium sulfide.
Telescope Innovations Corp. is based in Vancouver, Canada.
Telescope Innovations Corp.
| Country | Canada |
| Industry | Biotechnology |
| Sector | Healthcare |
| CEO | Henry Dubina |
Contact Details
Address: 301 - 2386 East Mall Vancouver, BC V6T 1Z3 Canada | |
| Phone | 778-262-1166 |
| Website | telescopeinnovations.com |
Stock Details
| Ticker Symbol | TELI |
| Exchange | Canadian Securities Exchange |
| Fiscal Year | September - August |
| Reporting Currency | CAD |
| ISIN Number | CA87953P1080 |
| SIC Code | 8731 |
Key Executives
| Name | Position |
|---|---|
| Henry Dubina | Chief Executive Officer and Chairman of Board |
| John Kirincic | Chief Financial Officer |
| Prof. Jason Hein | Chief Technology Officer and Director |
| Vaso Vlachos | Chief Operating Officer |
| Shad Grunert | Senior Vice President of Sales and Marketing |
| Deborah Cotter | Company Secretary |